ES549256A0 - Procedimiento para la obtencion de derivados de piperidina con actividad cardiovascular. - Google Patents

Procedimiento para la obtencion de derivados de piperidina con actividad cardiovascular.

Info

Publication number
ES549256A0
ES549256A0 ES549256A ES549256A ES549256A0 ES 549256 A0 ES549256 A0 ES 549256A0 ES 549256 A ES549256 A ES 549256A ES 549256 A ES549256 A ES 549256A ES 549256 A0 ES549256 A0 ES 549256A0
Authority
ES
Spain
Prior art keywords
procedure
obtaining
piperidine derivatives
cardiovascular activity
cardiovascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES549256A
Other languages
English (en)
Other versions
ES8701159A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Publication of ES549256A0 publication Critical patent/ES549256A0/es
Publication of ES8701159A1 publication Critical patent/ES8701159A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES549256A 1984-11-26 1985-11-25 Procedimiento para la obtencion de derivados de piperidina con actividad cardiovascular. Expired ES8701159A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/674,900 US4650874A (en) 1984-11-26 1984-11-26 N-(aralkoxybenzyl)-4(benzhydryl) piperidines

Publications (2)

Publication Number Publication Date
ES549256A0 true ES549256A0 (es) 1986-11-16
ES8701159A1 ES8701159A1 (es) 1986-11-16

Family

ID=24708349

Family Applications (1)

Application Number Title Priority Date Filing Date
ES549256A Expired ES8701159A1 (es) 1984-11-26 1985-11-25 Procedimiento para la obtencion de derivados de piperidina con actividad cardiovascular.

Country Status (7)

Country Link
US (1) US4650874A (es)
EP (1) EP0183216B1 (es)
JP (1) JPS61130280A (es)
AU (1) AU5031285A (es)
DE (1) DE3571612D1 (es)
ES (1) ES8701159A1 (es)
ZA (1) ZA859002B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632925A (en) * 1985-10-07 1986-12-30 Hoffmann-La Roche Inc. N-substituted diphenylpiperidines and antiobesity use thereof
FI874121A7 (fi) * 1986-09-24 1988-03-25 Sumitomo Chemical Co Heterocykliska foereningar, och deras framstaellning och anvaendning.
US5639763A (en) * 1994-03-01 1997-06-17 Fmc Corporation Insecticidal N-(substituted arylmethyl)-4-[bis(substituted phenyl)methyl]piperidines
US5569664A (en) * 1995-02-16 1996-10-29 Fmc Corporation Insecticidal n-(substituted arylmethyl)-4-[bis(substituted phenyl) methyl]pi
US6017931A (en) * 1994-03-01 2000-01-25 Fmc Corporation Insecticidal compositions containing n-(substituted phenylmethyl)-4-[bis(substituted phenyl)methyl]piperidines
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242169A (en) * 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives
GB1252315A (es) * 1969-06-05 1971-11-03
BE794598A (fr) * 1972-01-28 1973-05-16 Richardson Merrell Inc Nouveaux derives olefiniques de piperidines substituees en 4 et leur procede de preparation
US3956296A (en) * 1974-12-11 1976-05-11 A. H. Robins Company, Incorporated 1-Substituted-4-benzylpiperidines
US4035372A (en) * 1976-08-13 1977-07-12 G. D. Searle & Co. 4-{[4-(Diphenylmethyl)-1-piperidinyl]methyl}benzenamines
GB1542823A (en) * 1977-01-11 1979-03-28 Ucb Sa Piperidine derivatives
US4356184A (en) * 1980-06-04 1982-10-26 G. D. Searle & Co. Anti-allergic or antihypertensive 1-piperidinylmethyl benzenamines

Also Published As

Publication number Publication date
DE3571612D1 (de) 1989-08-24
EP0183216A1 (en) 1986-06-04
EP0183216B1 (en) 1989-07-19
AU5031285A (en) 1986-06-05
US4650874A (en) 1987-03-17
ZA859002B (en) 1987-01-28
JPS61130280A (ja) 1986-06-18
ES8701159A1 (es) 1986-11-16

Similar Documents

Publication Publication Date Title
ES557316A0 (es) Procedimiento para la obtencion de derivados de 5-amino-4-hidrovalerilo.
ES539281A0 (es) Un procedimiento para la preparacion de derivados de piperidina.
ES553084A0 (es) Procedimiento para la obtencion de acidos 7-amino-1-ciclopropil-6,8-dihalogeno-1,4-dihidro-4-oxo-3-quinolincarboxilico
ES540597A0 (es) Procedimiento para la obtencion de piridonas.
DE3580134D1 (de) Benzoesaeurederivate.
DE3579625D1 (de) Aminoalkylphenoxyderivate.
FI855087A0 (fi) Ytaktiv tvaettmedelssammansaettning foer textiler med effektivare rengoeringseffekt.
ES552397A0 (es) Procedimiento para la obtencion de poli-hidro piridazo diacepinas, triacepinas o diazocinas
ES555839A0 (es) Procedimiento para la obtencion de quinoloncarboxilatos.
ATE32711T1 (de) Fluorallylaminderivate.
ES542421A0 (es) Procedimiento para la obtencion de derivados de tetrahidro- quinolina-1-ilcarbonilimidazol.
DE3583726D1 (de) 5-fluoruracilderivate.
ES556082A0 (es) Procedimiento para preparar derivados de 1,4-dihidropiridina con actividad cardiovascular
ES540173A0 (es) Procedimiento para la obtencion de nuevos 1,3,2-dioxaborina-nos
DE3482590D1 (de) Carboxyalkyl-peptid-derivate.
ES541265A0 (es) Procedimiento para la obtencion de derivados de tiocianopi- rimidina
ES550351A0 (es) Procedimiento para la produccion de 8-alfa-acilamino-ergolinas.
ES543832A0 (es) Procedimiento para la obtencion de fenilsulfonilureas susti-tuidas
FI852064A7 (fi) Sykloalkaani-indeeni-karboksi -imidamidijohdannaisia.
ES539074A0 (es) Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
ES546557A0 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
ES549429A0 (es) Procedimiento para la obtencion de acemetacina.
ES546923A0 (es) Procedimiento para la obtencion de derivados de salicilamida
ATE36330T1 (de) Eburnanderivate.
ES547820A0 (es) Procedimiento de preparacion de nuevos derivados nucleosidos.